Browse drugs

…erapy. Three patients with poor prognostic factors treated with rituximab had a surprisingly good outcome.Interestingly, three patients d…

…subarachnoid hemorrhage, cerebral infarction), and medications (beta blockers, calcium channel blockers, antiarrhythmics, antilipemic agents,…

…vors. ACE inhibitors (ACEIs), angiotensin receptor blockers and beta blockers have been proposed as prophylactic therapies; however, the robu…

…ensin receptor blockers, diuretics, aldosterone antagonists and atenolol. Stage I hypertension was classified as an SBP of 140–159 mm Hg…

… (40%). In patients with reduced LVEF, the prescription rate of ACE inhibitors, angiotensin receptor blockers or angiotensin receptor-neprilys…

… pharmacological therapies—including statins, beta blockers and ACE inhibitors—accounting for 27.7% of the reduction (95% CI 26.0% to 29.5%). …

…single ventricles after bidirectional Glenn (BDG) are placed on ACE inhibitors (ACEIs) to reduce afterload and to decrease systemic to pulmona…

…hese neurohumoral pathways, most notably with beta-blockers and ACE inhibitors. At present, HF is defined as ‘a clinical syndrome with signs a…

…cribed (%) N = 76 Improvement (%) p-value Significant? (p<0.05) Aspirin 221 (100) 76 (100) 0 - - Beta-blocker 156 (70.6) 69 (90.8) +20.…

…iated during follow-up—may still exist. At baseline, the use of sodium–glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and glucagon-like pept…

…inhibitors or angiotensin receptor-neprilysin inhibitor (ARNI), beta-blockers, mineralocorticoid receptor antagonists (MRA) and sodium-glucos…

…CE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), statins) and treatment targets (blood pressure (BP) and HbA1c). Pooled …